-
Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma
讲者:方腾 -
使用非病毒方法将抗CD19 CAR序列定点整合于PD1位点的CD19 CAR-T细胞(PD1-19bbz)治疗复发/难治非霍奇金淋巴瘤的I期临床试验结果
讲者:祖成 -
A tRNA-derived small RNAs expression signature as a predictive and prognostic biomarker in Diffuse Large B Cell Lymphoma
讲者:饶军 -
Tafasitamab的中国真实世界数据
讲者:游建华 -
初诊伴有弥漫大B细胞成分的中国滤泡淋巴瘤患者的临床特征及生存分析
讲者:林志娟 -
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
讲者:沈容 -
Ixazomib versus Lenalidomide or Ixazomib and Lenalidomide combination as maintenance regimen for transplant-ineligible multiple myeloma: update of a multi-center prospective study in China
讲者:庄喆 -
淋巴瘤CAR-T治疗中的T细胞功能缺陷评估模型研究
讲者:汪佳晨 -
动态循环肿瘤DNA揭示B细胞非霍奇金淋巴瘤患者CAR-T细胞治疗失败的机制研究
讲者:周凌辉 -
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
讲者:闫子勋 -
Clinical and biological features and outcomes of patients with chronic lymphocytic leukemia: a real-world study of 2005 patients in China
讲者:陈佳雯 -
整合多组学技术解析CLL泽布替尼耐药的克隆演变模式及耐药克隆特征
讲者:朱华渊